Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming

The biological and clinical heterogeneity of neuroblastoma (NB) demands novel biomarkers and therapeutic targets in order to drive the most appropriate treatment for each patient. Hypoxia is a condition of low-oxygen tension occurring in poorly vascularized tumor tissues. In this study, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cangelosi, Davide, Morini, Martina, Zanardi, Nicolò, Sementa, Angela Rita, Muselli, Marco, Conte, Massimo, Garaventa, Alberto, Pfeffer, Ulrich, Bosco, Maria Carla, Varesio, Luigi, Eva, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563184/
https://www.ncbi.nlm.nih.gov/pubmed/32825087
http://dx.doi.org/10.3390/cancers12092343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563184/
https://www.ncbi.nlm.nih.gov/pubmed/32825087
http://dx.doi.org/10.3390/cancers12092343

Ejemplares similares